<Disease><Name>SARCOSINEMIA</Name><Synonym>SARCOSINE DEHYDROGENASE COMPLEX DEFICIENCY; HYPERSARCOSINEMIA</Synonym><OMIM><Number>268900</Number><URL>http://omim.org/entry/268900</URL></OMIM><Orphanet><Number>3129</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=3129</URL></Orphanet><Protein><Number>Sarcosine dehydrogenase, mitochondrial</Number><URL>http://www.uniprot.org/uniprot/Q9UL12</URL></Protein><ExPASy><Number>1.5.99.1</Number><URL>http://enzyme.expasy.org/EC/1.5.99.1</URL></ExPASy><Gene>9q34.2</Gene><ICD>E72.5</ICD><Summary>rare (1:350000, ~50 cases) ;autosomal recessive ;mutation in the SARDH gene;Sarcosinemia is caused by a defect in the conversion of sarcosine to glycine, it is most probably a benigne disorder Sarcosinemia also with Glutaric acidemia II and Folate deficiency (goats milk feeding!)</Summary><Symptoms><symtomp><id>2074</id><symptom>Amino acids, plasma</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2088</id><symptom>Amino acids, urine</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>1942</id><symptom>ataxia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2211</id><symptom>blindness, visual loss, visual impairment</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2104</id><symptom>cardiomyopathy</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>3803</id><symptom>craniostenosis</symptom><category>HEAD</category></symtomp><symtomp><id>3819</id><symptom>developmental delay</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1946</id><symptom>dystonia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2095</id><symptom>failure to thrive</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp><symtomp><id>1979</id><symptom>feeding difficulties, poor feeding</symptom><category>GASTROINTESTINAL SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1882</id><symptom>growth retardation, poor growth</symptom><category>GENERAL TOPICS | GENERAL TOPICS</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1717</id><symptom>no clinical symptoms (probably) / no clinical  significance</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1980</id><symptom>vomiting</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp></Symptoms><Metabolites><metabolite><id>1685</id><name>Sarcosine</name><specimen>urine</specimen><value>increased</value><min>0.50</min><max>5.40</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1783</id><name>Sarcosine</name><specimen>urine</specimen><value>increased</value><min>5.00</min><max>25.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>141</id><name>Sarcosine</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>625.00</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>142</id><name>Sarcosine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>56.00</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>7524</id><title>Chemically induced acute model of sarcosinemia in wistar rats</title><author>de Andrade RB,</author><journal>Metab Brain Dis</journal><year>2016</year><book /><volume>31</volume><number>2</number><pages>363-368</pages><co_aut>et al.</co_aut></literature><literature><id>7525</id><title>A young adult with sarcosinemia. No benefit from long duration treatment with memantine</title><author>Benarrosh A,</author><journal>JIMD Rep</journal><year>2013</year><book /><volume>9</volume><number>0</number><pages>93-96</pages><co_aut>et al.</co_aut></literature><literature><id>7526</id><title>Mutations in the sarcosine dehydrogenase gene in patients with sarcosinemia</title><author>Bar-joseph I,</author><journal>Hum Genet</journal><year>2012</year><book /><volume>131</volume><number>11</number><pages>1805-1810</pages><co_aut>et al.</co_aut></literature><literature><id>4969</id><title>Rare neurodevelopmental abnormalities of sarcosinemia may involve glycinergic stimulation of a primed N-methyl-d-aspartate rece</title><author>Deutsch SI,</author><journal>Clin Neuropharmacol</journal><year>2006</year><book /><volume>29</volume><number>6</number><pages>361-363</pages><co_aut>et al.</co_aut></literature><literature><id>2033</id><title>[Molecular clonging of the human dimethyglycine dehydrogenase-like gene (DMGDHL1) from the sarcosinemia critical region at 9q34</title><author>Xia JH</author><journal>Yi Chuan Xue Bao</journal><year>1999</year><book /><volume>26</volume><number>6</number><pages>591-597</pages><co_aut>et al.</co_aut></literature><literature><id>2034</id><title>Cloning and mapping of the cDNA for human sarcosine dehydrogenase, a flavoenzyme defective in patients with sarcosinemia</title><author>Eschenbrenner M</author><journal>Genomics</journal><year>1999</year><book /><volume>59</volume><number>3</number><pages>300-308</pages><co_aut>Jorns MS</co_aut></literature><literature><id>2035</id><title>[Sarcosinemia associated with folate deficiency]</title><author>Hiraga K</author><journal>Ryoikibetsu Shokogun Shirizu</journal><year>1998</year><book /><volume>18</volume><number>1</number><pages>224-226</pages><co_aut /></literature><literature><id>769</id><title>Sarcosinaemia in a patient with severe progressive neurological damage and hypertrophic cardiomyopathy</title><author>Meissner T</author><journal>J Inherit Metab Dis</journal><year>1997</year><book /><volume>20</volume><number>0</number><pages>717-718</pages><co_aut>Mayatepek E</co_aut></literature><literature><id>409</id><title>Sarcosinemia</title><author>Scott CR</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>1</volume><number>0</number><pages>1329-1335</pages><co_aut /></literature><literature><id>2036</id><title>Sarcosinaemia in a retarded, amaurotic child</title><author>Sewell AC</author><journal>Eur J Pediatr</journal><year>1986</year><book /><volume>144</volume><number>5</number><pages>508-510</pages><co_aut>Krille M, Wilhelm I</co_aut></literature><literature><id>768</id><title>Hypersarcosinaemia: an inborn error of metabolism</title><author>Gerritsen T</author><journal>N Engl J Med</journal><year>1966</year><book /><volume>275</volume><number>0</number><pages>66-69</pages><co_aut>Waisman HA</co_aut></literature></Literatures></Disease>